FGC
TEVA icon

Financial Gravity Companies’s Teva Pharmaceuticals TEVA Stock Holding History

Financial Gravity Companies’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$0 Buy
11
+9
+450% +$176 ﹤0.01% 1639
2017
Q4 		$0 Buy
+2
New +$30 ﹤0.01% 1465

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Gravity Companies's TEVA Position: Q1 2018 in Review

Financial Gravity Companies increased its Teva Pharmaceuticals (TEVA) stake by 450% in Q1 2018, buying an estimated $176 and bringing the position to 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Financial Gravity Companies first reported a position in TEVA in Q4 2017 and has held it in 2 quarters since. 506 funds tracked by Wall St. Rank hold TEVA as of Q1 2018.

  • Financial Gravity Companies held 11 shares of Teva Pharmaceuticals worth $0 as of Q1 2018.
  • Financial Gravity Companies bought 9 Teva Pharmaceuticals shares in Q1 2018, an estimated $176.
  • Teva Pharmaceuticals made up ﹤0.01% of Financial Gravity Companies's portfolio in Q1 2018, its #1639 holding.
  • Financial Gravity Companies first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 2 quarters since.
  • 506 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2018.

Based on Financial Gravity Companies's 13F filing for Q1 2018, filed 4 May 2018.